世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の移植検査市場:製品・サービス(機器、試薬・消耗品)、スクリーニングタイプ(移植前、移植後)、臓器タイプ(腎臓、肝臓、心臓、肺)、用途タイプ、エンドユーザーの情報と2023年までの予測

Global Transplant Diagnostics Market Information, Product & Service (Instruments, Reagents & Consumables), Screening Type (Pre-Transplant, Post-Transplant), Organ Type (Kidney, Liver, Heart, Lung, Pancreas), Application Type, End-User - Forecast to 2023

 

出版社 出版年月電子版価格 ページ数
Market Research Future
マーケットリサーチフューチャー (MRFR)
2019年1月US$4,450
シングルユーザライセンス
215

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは世界の移植検査市場を分析・予測したMarket Research Futureの市場調査報告書です。

Overview

Introduction
Transplant diagnostic is a test which is performed during organ transplantation to identify the compatibility of the organ. It is a medical procedure in which an organ is removed from one body and placed in another to swap the damaged or missing organ. The transplant diagnostic test is mainly performed to reduce the risk of organ rejection. Organ transplantation is performed to treat organ failures such as lungs, liver, kidney, and many more. The rising incidence of chronic and infectious diseases, increasing awareness related to transplant diagnostic procedures, and growing number of stem cell, soft-tissue, and solid organ transplantations are projected to drive market growth over the forecast period.
However, strict regulatory bodies and stringent regulatory policies are expected to restrain market growth during the forecast period.
The global transplant diagnostics market has been segmented, by product and service, screening type, organ type, application type, and end user.
Based on product and service, the global transplant diagnostics market has been categorized as instruments, reagents and consumables, and software and services.
On the basis of screening type, the global transplant diagnostics market is further sub-segmented into pre-transplant screening and post-transplant screening.
By organ type, the global transplant diagnostics market is further sub-segmented into kidney, liver, heart, lung, pancreas, and others.
On the basis of application type, the global transplant diagnostics market is further sub-segmented into research application, diagnostics applications, and others.
On the basis of end user, the market has been classified as commercial services providers, hospitals and transplant centers, research laboratories, and academics institutes and others
The global transplant diagnostics market was valued at USD 1,326.4 million in 2017 and is expected to register a CAGR of 7.81% during the forecast period from 2018 to 2023.
Key Players
Some of the key players in the global transplant diagnostics market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche AG, Qiagen N.V, BioMerieux SA, Illumina, Inc, Becton, Dickinson and Company, Caredx, Inc, Gendx, Zimmer Biomet, Medtronic PLC, DiaSorin S.P.A, Merck KGaA, and Immucor, Inc.
Objectives of the Study
- To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global transplant diagnostics market
- To provide insights into factors influencing and affecting market growth
- To provide historical and forecast revenue of market segments and sub-segments with respect to countries
- To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
- To provide economic factors that influence the global transplant diagnostics market
- To provide a detailed analysis of the value chain and supply chain of the global transplant diagnostics market
Target Audience
- Research and Development (R&D) Companies
- Academic Institutes and Universities
- Pharmaceutical Companies
- Raw Material Suppliers
- Suppliers and Distributors
- Transplant Diagnostics Kits Manufacturers
- Government
- Potential Investors

Key Findings
- The global transplant diagnostics market is expected to reach USD 2,074.7 million by 2023 at a CAGR of 7.81% from 2018 to 2023
- Based on products and services, the reagents and consumables segment holds the largest market share and is expected to reach USD 1,027.54 million by 2023 at a CAGR of 8.4% from 2018 to 2023
- The market in the Americas is expected to account for the largest share of the global transplant diagnostics market and is projected to reach USD 666.78 million by 2023
- The transplant diagnostics market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 8.52% from 2018 to 2023
Regional Analysis
- Americas
o North America
- US
- Canada
o Latin America
- Europe
o Western Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Western Europe
o Eastern Europe
- Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
- Middle East & Africa
o Middle East
o Africa



目次

Table of Contents

Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Scope of Study
3.2 Research Objective
3.3 List of Assumptions
3.4 Market Structure
4 Research Methodology
4.1 Primary Research Methodology
4.2 Data points received from the Specialist Doctors:
4.3 Data points received from the Manufacturer/ Pharmaceutical Companies:
4.4 Data points received from Hospitals, Diagnostic Centers:
4.5 Secondary Research Methodology
4.6 Market Share Analysis
4.7 Trade Analysis
4.8 Market Pricing Approach
4.9 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Growing number of stem cell, soft-tissue, and solid organ, transplantation procedures
5.2.2 Rising occurrence of chronic and infectious diseases
5.2.3 Increasing Awareness Related to Transplant Diagnostic Procedures
5.3 Restraints
5.3.1 Shortage of donor organ and limited medical reimbursement
5.3.2 High cost of NGS- and PCR-based devices
5.4 Opportunities
5.4.1 High demand for tissue engineering in cosmetic and reconstructive surgery
5.4.2 Growing geriatric population presents a significant growth opportunity
6 Market Factor Analysis
6.1 Porters Five Forces Analysis
6.1.1 Bargaining Power of Suppliers
6.1.2 Bargaining Power of Buyers
6.1.3 Threat of New Entrants
6.1.4 Threat of Substitutes
6.1.5 Intensity of Rivalry
6.2 Supply Chain Analysis
6.2.1 Primary activities
6.2.2 Secondary Activities
7 Immunosuppressant Drug Monitoring (ISD)
7.1 Overview
7.1 Diagnostic Tests for Transplantation
7.1.1 Therapeutic Drug Monitoring During Transplantation
7.2 Americas
7.2.1 North America
7.2.1.1 U.S.
7.2.1.2 Canada
7.2.2 South America
7.3 Europe
7.3.1 Germany
7.3.2 U.K
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 Rest of Asia Pacific
7.5 Middle East & Africa
7.5.1 Middle East
7.5.2 Africa
8 Global Transplant Diagnostics Market, By Products and Services
8.1 Introduction
8.1.1 Instruments
8.1.2 Reagents & Consumables
8.1.3 Software and Services
9 Global Transplant Diagnostics Market, By Screening Type
9.1 Introduction
9.1.1 Pre-Transplant Screening
9.1.2 Post-Transplant Screening
10 Global Transplant Diagnostics Market, By Organ Type
10.1 Introduction
10.1.1 Kidney
10.1.2 Liver
10.1.3 Heart
10.1.4 Lung
10.1.5 Pancreas
11 Global Transplant Diagnostics Market, By Application Type
11.1 Introduction
11.1.1 Research Applications
11.1.2 Diagnostic Applications
12 Global Transplant Diagnostics Market, By End User
12.1 Introduction
12.1.1 Commercial Service Providers
12.1.2 Hospitals and Transplant Centres
12.1.3 Research Laboratories and Academic Institutes
13 Global Transplant Diagnostics Market, By Region
13.1 Introduction
13.2 Americas
13.2.1 North America
13.2.1.1 U.S.
13.2.1.2 Canada
13.2.2 South America
13.3 Europe
13.3.1 Germany
13.3.2 U.K
13.3.3 France
13.3.4 Spain
13.3.5 Italy
13.3.6 Rest of Europe
13.4 Asia Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 Australia
13.4.5 Rest of Asia Pacific
13.5 Middle East & Africa
13.5.1 Middle East
13.5.2 Africa
14 Competitive Landscape
14.1 Company Market Share Analysis
14.1.1 Introduction
14.2 Competitive Landscape
14.2.1 Introduction
14.3 Key Developments
15 Company Profiles
15.1 Thermo Fisher Scientific Inc.
15.1.1 Company Overview
15.1.2 Financial Overview
15.1.3 Products Offering
15.1.4 Key Developments
15.1.5 SWOT Analysis
15.1.6 Key Strategy
15.2 Bio-Rad Laboratories, Inc.
15.2.1 Company Overview
15.2.2 Financial Overview
15.2.3 Products Offering
15.2.4 Key Developments
15.2.5 SWOT Analysis
15.2.6 Key Strategy
15.3 F. Hoffmann-La Roche AG
15.3.1 Company Overview
15.3.2 Financial Overview
15.3.3 Products Offering
15.3.4 Key Developments
15.3.5 SWOT Analysis
15.3.6 Key Strategy
15.4 Qiagen N.V.
15.4.1 Company Overview
15.4.2 Financial Overview
15.4.3 Products Offering
15.4.4 Key Developments
15.4.5 SWOT Analysis
15.4.6 Key strategy
15.5 BioMerieux SA
15.5.1 Company Overview
15.5.2 Financial Overview
15.5.3 Products Offering
15.5.4 Key Developments
15.5.5 SWOT Analysis
15.5.6 Key Strategy
15.6 Illumina, Inc.
15.6.1 Company Overview
15.6.2 Financial Overview
15.6.3 Products Offering
15.6.4 Key Developments
15.6.5 SWOT Analysis
15.6.6 Key Strategy
15.7 Becton, Dickinson and Company
15.7.1 Company Overview
15.7.2 Financial Overview
15.7.3 Products Offering
15.7.4 Key Developments
15.7.5 SWOT Analysis
15.7.6 Key Strategy
15.8 Caredx, Inc.
15.8.1 Company Overview
15.8.2 Financial Overview
15.8.3 Products Offering
15.8.4 Key Developments
15.8.5 SWOT Analysis
15.8.6 Key Strategy
15.9 Gendx
15.9.1 Company Overview
15.9.2 Financial Overview
15.9.3 Products Offering
15.9.4 Key Developments
15.9.5 SWOT Analysis
15.9.6 Key Strategy
15.1 Zimmer Biomet
15.10.1 Company Overview
15.10.2 Financial Overview
15.10.3 Products Offering
15.10.4 Key Developments
15.10.5 SWOT Analysis
15.10.6 Key Strategy
15.11 Medtronic PLC
15.11.1 Company Overview
15.11.2 Financial Overview
15.11.3 Products Offering
15.11.4 Key Developments
15.11.5 SWOT Analysis
15.11.6 Key Strategy
15.12 DiaSorin S.P.A
15.12.1 Company Overview
15.12.2 Financial Overview
15.12.3 Products Offering
15.12.4 Key Developments
15.12.5 SWOT Analysis
15.12.6 Key Strategy
15.13 Merck KGaA
15.13.1 Company Overview
15.13.2 Financial Overview
15.13.3 Products Offering
15.13.4 Key Developments
15.13.5 SWOT Analysis
15.13.6 Key Strategy
15.14 Immucor, Inc.
15.14.1 Company Overview
15.14.2 Financial Overview:
15.14.3 Products Offering
15.14.4 Key Developments
15.14.5 SWOT Analysis
15.14.6 Key strategy
16 Appendix
16.1 Discussion Blue Print
16.2 Reference

List of Tables

List of Tables:

TABLE 1 MARKET SYNOPSIS
TABLE 2 LIST OF ASSUMPTIONS
TABLE 3 PRIMARY INTERVIEWS
TABLE 4 GLOBAL IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 5 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 6 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 7 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
2015-2023 (USD MILLION)
TABLE 8 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2015-2023 (USD MILLION)
TABLE 9 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 10 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 11 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)
TABLE 12 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 13 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 14 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)
TABLE 15 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 16 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
2015-2023 (USD MILLION)
TABLE 17 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2015-2023 (USD MILLION)
TABLE 18 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 19 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 20 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 21 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)
TABLE 22 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 23 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 24 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)
TABLE 25 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 26 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 27 U.K TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 28 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 29 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 30 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)
TABLE 31 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 32 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 33 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)
TABLE 34 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 35 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 36 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023
(USD MILLION)
TABLE 37 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 38 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
2015-2023 (USD MILLION)
TABLE 39 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2015-2023 (USD MILLION)
TABLE 40 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 41 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 42 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 43 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2015-2023 (USD MILLION)
TABLE 44 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 45 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 46 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)
TABLE 47 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 48 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 49 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)
TABLE 50 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 51 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 52 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)
TABLE 53 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 54 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 55 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2015-2023 (USD MILLION)
TABLE 56 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 57 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 58 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2015-2023 (USD MILLION)
TABLE 59 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
2015-2023 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2015-2023 (USD MILLION)
TABLE 63 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 64 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 65 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2015-2023 (USD MILLION)
TABLE 66 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 67 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)
TABLE 68 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)
TABLE 69 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)
TABLE 70 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 71 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 72 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 73 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 74 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 75 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 76 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION 2015-2023 (USD MILLION)
TABLE 77 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR REAGENTS & CONSUMABLES, BY REGION 2015-2023 (USD MILLION)
TABLE 78 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION 2015-2023 (USD MILLION)
TABLE 79 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 80 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR PRE-TRANSPLANT SCREENING, BY REGION 2015-2023 (USD MILLION)
TABLE 81 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR POST-TRANSPLANT SCREENING, BY REGION 2015-2023 (USD MILLION)
TABLE 82 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 83 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR KIDNEY, BY REGION 2015-2023 (USD MILLION)
TABLE 84 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR LIVER, BY REGION 2015-2023 (USD MILLION)
TABLE 85 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR HEART, BY REGION 2015-2023 (USD MILLION)
TABLE 86 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR LUNG, BY REGION 2015-2023 (USD MILLION)
TABLE 87 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR PANCREAS, BY REGION 2015-2023 (USD MILLION)
TABLE 88 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 89 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 90 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH APPLICATIONS, BY REGION 2015-2023 (USD MILLION)
TABLE 91 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION 2015-2023 (USD MILLION)
TABLE 92 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 93 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR COMMERCIAL SERVICE PROVIDERS, BY REGION 2015-2023 (USD MILLION)
TABLE 94 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR HOSPITALS AND TRANSPLANT CENTERS, BY REGION
2015-2023 (USD MILLION)
TABLE 95 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION
2015-2023 (USD MILLION)
TABLE 96 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 97 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 98 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 99 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 100 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 101 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 102 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 103 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 104 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 105 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 106 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 107 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 108 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 109 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 110 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 111 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 112 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 113 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 114 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 115 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 116 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 117 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 118 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 119 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 120 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 121 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 122 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 123 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 124 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 125 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 126 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 127 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 128 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 129 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 130 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 131 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 132 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 133 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 134 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 135 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 136 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 137 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 138 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 139 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 140 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 141 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 142 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 143 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 144 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 145 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 146 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 147 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 148 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 149 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 150 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 151 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 152 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 153 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 154 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 155 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 156 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 157 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 158 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 159 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 160 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 161 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 162 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 163 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 164 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 165 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 166 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 167 U.K TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 168 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 169 U.K TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 170 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 171 U.K TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 172 U.K TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 173 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 174 U.K TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 175 U.K TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 176 U.K TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 177 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 178 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 179 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 180 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 181 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 182 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 183 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 184 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 185 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 186 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 187 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 188 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 189 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 190 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 191 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 192 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 193 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 194 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 195 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 196 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 197 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 198 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 199 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 200 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 201 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 202 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 203 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 204 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 205 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 206 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 207 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 208 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 209 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 210 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 211 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 212 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 213 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 214 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 215 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 216 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 217 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 218 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 219 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 220 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 221 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 222 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 223 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 224 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 225 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 226 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 227 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 228 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 229 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 230 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 231 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 232 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 233 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 234 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 235 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 236 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 237 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 238 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 239 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 240 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 241 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 242 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 243 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 244 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 245 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 246 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 247 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 248 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 249 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 250 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)
TABLE 251 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)
TABLE 252 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 253 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)
TABLE 254 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 255 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)
TABLE 256 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)
TABLE 257 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)
TABLE 258 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)
TABLE 259 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)
TABLE 260 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)
これ以降の目次はメールでお送りいたします。データリソースまでお申し付けください。

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る